AC
MRTX
Armistice Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-500,000
| Closed | -$29.4M | – | 429 |
|
|
2023
Q4 | $29.4M | Sell |
500,000
-864,098
| -63% | -$50.8M | 0.4% | 42 |
|
|
2023
Q3 | $59.4M | Sell |
1,364,098
-2,613,902
| -66% | -$114M | 0.91% | 16 |
|
|
2023
Q2 | $144M | Buy |
3,978,000
+286,000
| +8% | +$10.3M | 2.08% | 3 |
|
|
2023
Q1 | $137M | Buy |
3,692,000
+204,000
| +6% | +$7.58M | 1.98% | 5 |
|
|
2022
Q4 | $158M | Buy |
3,488,000
+1,588,000
| +84% | +$72M | 2.76% | 1 |
|
|
2022
Q3 | $133M | Sell |
1,900,000
-148,000
| -7% | -$10.3M | 2.3% | 7 |
|
|
2022
Q2 | $137K | Buy |
2,048,000
+684,000
| +50% | +$45.9K | 2.4% | 4 |
|
|
2022
Q1 | $112M | Buy |
1,364,000
+528,000
| +63% | +$43.4M | 2.17% | 5 |
|
|
2021
Q4 | $123M | Buy |
836,000
+126,000
| +18% | +$18.5M | 2.01% | 4 |
|
|
2021
Q3 | $126M | Buy |
710,000
+50,000
| +8% | +$8.85M | 2.13% | 3 |
|
|
2021
Q2 | $107M | Buy |
660,000
+124,000
| +23% | +$20M | 1.91% | 5 |
|
|
2021
Q1 | $91.8M | Buy |
536,000
+264,000
| +97% | +$45.2M | 2.11% | 3 |
|
|
2020
Q4 | $59.7M | Buy |
272,000
+104,000
| +62% | +$22.8M | 2.03% | 8 |
|
|
2020
Q3 | $27.9M | Sell |
168,000
-104,000
| -38% | -$17.3M | 1.01% | 38 |
|
|
2020
Q2 | $31.1M | Sell |
272,000
-40,000
| -13% | -$4.57M | 1.36% | 24 |
|
|
2020
Q1 | $24M | Buy |
312,000
+192,000
| +160% | +$14.8M | 1.48% | 22 |
|
|
2019
Q4 | $15.5M | Buy |
+120,000
| New | +$15.5M | 0.89% | 31 |
|